Regulatory Affairs Syndicator

Regulatory Affairs Updates and Bulletins by Joe Schwoebel

  • Blog
  • Warning Letters
  • FDA Links
  • Resource
  • Register


« Philadelphia Hormone Therapy Trial Completed - PR Newswire (press release)
Pepsi to disclose caffeine content on labels - NutraIngredients-usa.com »

FDA Issues New Warning About Asthma Drug Xolair - Newsinferno.com

Published by Google Inc. February 21st, 2007 in Google FDA News, Regulatory Affairs


SpiritIndia
FDA Issues New Warning About Asthma Drug Xolair
Newsinferno.com, NY - 1 hour ago
Citing reports of severe, potentially fatal allergic reactions, the US Food and Drug Administration (FDA) has issued a new warning about omalizumab, …
Xolair Linked to Risk for Delayed-Onset Anaphylaxis Medscape (subscription)
FDA Proposes to Strengthen Label Warning for Xolair eMaxHealth.com
FDA Mandates Stronger Warning on Asthma Drug Xolair HealthCentral.com
Smartmoney.com - Pharma Times (subscription)
all 168 news articles

Search



Regulatory Affairs Syndicator is powered by WordPress 2.0.3 and K2 Beta Two r167 by Michael and Chris
RSS Entries and RSS Comments